Return to search results
Lenalidomide
Lenalidomide is a prescription drug, a thalidomide analog, used to treat certain blood cancers like multiple myeloma. Manufactured by Mylan Pharmaceuticals Inc. as generic capsules in strengths of 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg, taken orally. Application number: ANDA213912. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Lenalidomide is a prescription drug, a thalidomide analog, used to treat certain blood cancers like multiple myeloma. Manufactured by Mylan Pharmaceuticals Inc. as generic capsules in strengths of 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg, taken orally. Application number: ANDA213912. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Lenalidomide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Lenalidomide — ANDA 209348 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209348"
}
]
|
| identifier | ANDA209348 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"health-care",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Lenalidomide |
